Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Agricultural Inputs

Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company`s crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.
Website: arcadiabio.com



Growth: Bad revenue growth rate -50.0%, there is slowdown compared to average historical growth rates -21.5%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +50.0%. On average the margin is decreasing steadily. Gross margin is normal, +32.1%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$1.94 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -64.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 24.7% higher than minimum and 83.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.4x by EV / Sales multiple

Key Financials (Download financials)

Ticker: RKDA
Share price, USD:  (0.0%)2.27
year average price 3.73  


year start price 4.85 2025-02-07

max close price 5.48 2025-10-17

min close price 1.82 2025-12-30

current price 2.27 2026-02-06
Common stocks: 1 367 192

Dividend Yield:  0.0%
FCF Yield LTM: -64.4%
EV / LTM EBITDA: 500.0x
EV / Sales: -0.7x
Margin (EBITDA LTM / Revenue): 50.0%
Fundamental value created in LTM:
Market Cap ($m): 3
Net Debt ($m): -6
EV (Enterprise Value): -3
Price to Book: 0.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-12-26globenewswire.com

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

2025-05-11seekingalpha.com

Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript

2025-03-20seekingalpha.com

Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript

2025-03-06businesswire.com

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call

2025-02-24businesswire.com

RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders

2024-12-09zacks.com

Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%

2024-12-06prnewswire.com

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Arcadia Biosciences, Inc. - RKDA

2024-12-06prnewswire.com

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arcadia Biosciences, Inc.

2024-12-06businesswire.com

Shareholder Alert: Ademi LLP investigates whether Arcadia Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders

2024-12-05businesswire.com

RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-07 2025-08-14 2024-11-12 2024-08-13 2024-05-13 2023-11-09 2023-08-10 2023-05-15 2022-11-10 2022-08-11
acceptedDate 2025-11-07 16:15:06 2025-08-14 17:02:38 2025-04-30 16:08:32 2024-11-12 17:00:09 2024-08-13 17:16:56 2024-05-13 15:31:07 2024-04-29 14:07:07 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18 2022-03-31 17:30:23 2021-03-31 17:00:35
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 1M 1M 5M 2M 1M 1M 4M 2M 1M 2M 7M 2M 4M 7M 8M
costOfRevenue 884 000 824 000 3M 1M 633 000 820 000 2M 1M 981 000 825 000 6M 1M 3M 9M 5M
grossProfit 418 000 631 000 2M 505 000 673 000 435 000 2M 495 000 408 000 684 000 1M 534 000 411 000 -2M 3M
grossProfitRatio 0.321 0.434 0.329 0.515 0.347 0.31 0.294 0.453 0.284 0.107
researchAndDevelopmentExpenses 0 9000 53 000 24 000 10000 272 000 64 000 305 000 391 000 359 000 2M 255 000 359 000 4M 8M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16M
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 2M 2M 10M 2M 3M 3M 8M 3M 4M 4M 15M 5M 5M 23M 16M
otherExpenses 0 -1 000 000 -4M 0 0 3000 84 000 17 000 -13 000 32 000 -1M 0 0 7M -9M
operatingExpenses 2M 1M 6M 2M 3M 3M 8M 4M 4M 5M 15M 5M 5M 34M 16M
costAndExpenses 2M 2M 9M 3M 3M 4M 11M 5M 5M 6M 21M 6M 8M 42M 21M
interestIncome 7000 9000 782 000 233 000 150 000 45 000 695 000 133 000 207 000 0 289 000 0 0 0 0
interestExpense 0 0 0 0 0 0 0 0 0 198 000 0 95 000 30 000 20 000 47 000
depreciationAndAmortization 2000 15 000 113 000 7000 34 000 228 000 287 000 89 000 67 000 -38 000 479 000 -2M 141 000 1M 662 000
ebitda 858 000 -1M -7M -2M -2M -3M -6M -3M -8M -4M -15M -6M -4M -28M -5M
ebitdaratio 0.659 -1.021 -1.141 -1.521 -2.229 -2.03 -5.87 -2.708 -3.366 -0.94
operatingIncome -1M -501 000 -4M -2M 2M -3M -6M -3M -4M -4M -14M -5M -4M -36M -13M
operatingIncomeRatio -0.885 -0.344 -1.145 1.516 -2.411 -2.03 -2.729 -2.683 -2.426 -0.981
totalOtherIncomeExpensesNet 2M -4M -661 000 578 000 -130 000 603 000 781 000 758 000 4M 19 000 3M 2M -14 000 19M 7M
incomeBeforeTax 856 000 -4M -4M -1M 2M -2M -5M -2M 819 000 -4M -11M -3M -4M -16M -6M
incomeBeforeTaxRatio 0.657 -3.064 -0.769 1.417 -1.931 -1.555 0.59 -2.683 -1.531 -0.984
incomeTaxExpense 0 0 8000 430 000 0 184 724 8000 83 000 1000 -198 000 14 000 1000 -20 000 2000 -124 000
netIncome 856 000 -4M -7M -2M 1M -2M -14M -3M 823 000 -4M -15M -3M -4M -15M -5M
netIncomeRatio 0.657 -3.064 -1.049 0.812 -1.931 -1.607 0.593 -2.551 -1.532 -0.979
eps 0.62 -3.26 -5.16 -1.18 0.78 -1.78 -11.3 -1.89 0.61 -4.49 -26.05 -4.69 -0.17 -30.33 -24.2
epsdiluted 0.62 -3.26 -1.18 0.78 -1.78 -1.89 0.61 -4.49 -4.69 -0.17
weightedAverageShsOut 1M 1M 1M 1M 1M 1M 1M 1M 1M 857 572 599 389 613 813 22M 532 015 248 975
weightedAverageShsOutDil 1M 1M 1M 1M 1M 1M 1M 1M 1M 857 572 599 389 613 813 22M 532 015 248 975
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-04-30 2024-04-29 2023-03-30 2022-03-31 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 782 000 695 000 289 000 -20 000 -47 000
ebit -8M -6M -15M -29M -6M
nonOperatingIncomeExcludingInterest 4M -84 000 1M -7M -7M
netIncomeFromContinuingOperations -4M -5M -11M -16M -6M
netIncomeFromDiscontinuedOperations -3M -9M -5M 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -7M -14M -15M -15M -5M
epsDiluted -5.16 -11.3 -26.05 -30.33 -24.2

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-07 2025-08-14 2024-11-12 2024-08-13 2024-05-13 2023-11-09 2023-08-10 2023-05-15 2022-11-10 2022-08-11
acceptedDate 2025-11-07 16:15:06 2025-08-14 17:02:38 2025-03-25 16:44:32 2024-11-12 17:00:09 2024-08-13 17:16:56 2024-05-13 15:31:07 2024-04-29 14:07:07 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18 2022-03-31 17:30:23 2021-03-31 17:00:35
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 1M 1M 4M 4M 6M 3M 7M 11M 13M 23M 21M 23M 21M 29M 14M
shortTermInvestments 5M 3M 0 3M 3M 5M 5M 5M 5M 0 0 0 0 0 12M
cashAndShortTermInvestments 6M 4M 4M 7M 8M 9M 12M 16M 19M 23M 21M 23M 21M 29M 26M
netReceivables 831 000 1M 1M 3M 3M 760 000 514 000 304 000 630 000 923 000 1M 3M 4M 1M 1M
inventory 1M 1M 904 000 835 000 978 000 2M 2M 3M 3M 3M 2M 3M 3M 4M 4M
otherCurrentAssets 214 000 383 000 2M 591 000 749 000 550 000 858 000 1M 951 000 606 000 1M 990 000 2M 0 0
totalCurrentAssets 8M 8M 9M 11M 12M 12M 15M 20M 23M 27M 25M 30M 30M 35M 32M
propertyPlantEquipmentNet 10000 22 000 178 000 361 000 567 000 1M 1M 2M 2M 2M 3M 3M 3M 5M 9M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 408 000
intangibleAssets 39 000 39 000 39 000 39 000 39 000 39 000 39 000 40 000 40 000 40 000 40 000 373 000 386 000 484 000 370 000
goodwillAndIntangibleAssets 39 000 39 000 39 000 39 000 39 000 39 000 39 000 40 000 40 000 40 000 40 000 373 000 386 000 484 000 778 000
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 148 000 148 000 4M 4M 4M 3M 4M 2M 1M 925 000 956 000 1M 1M 3M 6M
totalNonCurrentAssets 197 000 209 000 4M 5M 5M 4M 5M 3M 3M 3M 4M 4M 5M 9M 16M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 9M 8M 14M 15M 17M 16M 20M 23M 27M 30M 29M 34M 35M 44M 47M
accountPayables 2M 2M 703 000 2M 2M 2M 801 000 3M 3M 3M 905 000 3M 3M 1M 726 000
shortTermDebt 0 11 000 0 0 1M 801 000 0 924 000 993 000 1M 0 986 000 994 000 0 1M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 46 000 33 000 0 0 0 0 0 8000
otherCurrentLiabilities 270 000 270 000 483 000 636 000 12 000 345 000 634 000 313 000 282 000 298 000 296 000 317 000 355 000 264 000 263 000
totalCurrentLiabilities 2M 2M 3M 2M 3M 3M 4M 4M 4M 4M 4M 4M 5M 5M 6M
longTermDebt 0 0 0 0 11 000 21 000 0 347 000 532 000 760 000 0 1M 2M 0 2M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 856 000 1M 5M 3M 3M 3M 3M 4M 4M 9M 3M 2M 2M 5M 5M
totalNonCurrentLiabilities 856 000 1M 5M 3M 3M 3M 3M 4M 5M 10M 4M 5M 4M 8M 12M
otherLiabilities 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 11 000 155 000 0 574 000 21 000 1M 1M 2M 2M 2M 2M 2M 3M 6M
totalLiabilities 3M 3M 7M 5M 6M 6M 7M 8M 9M 14M 8M 9M 8M 13M 19M
preferredStock 0 0 0 0 0 0 0 2M 0 0 0 0 0 0 0
commonStock 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 65 000 63 000 63 000 54 000
retainedEarnings -280M -281M -279M -275M -273M -274M -272M -269M -266M -267M -258M -254M -251M -226M -212M
accumulatedOtherComprehensiveIncomeLoss -0 0 0 117 000 81 000 161 000 101 000 87 000 21 000 0 0 0 0 0 0
othertotalStockholdersEquity 285M 285M 285M 285M 285M 283M 284M 284M 279M 277M
totalStockholdersEquity 5M 5M 6M 10M 12M 11M 13M 16M 18M 17M 21M 25M 27M 31M 28M
totalEquity 5M 5M 6M 10M 12M 10M 13M 15M 18M 17M 21M 25M 27M 31M 29M
totalLiabilitiesAndStockholdersEquity 9M 8M 15M 17M 16M 23M 27M 30M 34M 35M
minorityInterest 0 0 0 -138 000 -138 000 -138 000 -138 000 -138 000 -138 000 -133 000 -133 000 0 0 103 000 827 000
totalLiabilitiesAndTotalEquity 9M 8M 14M 15M 17M 16M 20M 23M 27M 30M 29M 34M 35M 44M 47M
totalInvestments 5M 3M 0 3M 3M 5M 5M 5M 5M 0 0 0 0 0 12M
totalDebt 0 11 000 155 000 346 000 574 000 822 000 1M 1M 2M 2M 2M 2M 2M 3M 9M
netDebt -1M -1M -4M -4M -5M -2M -6M -9M -12M -21M -19M -20M -19M -25M -5M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-03-25 2024-04-29 2023-03-30 2022-03-31 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 1M 514 000 1M 1M 1M
otherReceivables 0 0 0 0 0
prepaids 931 000 0 0 900 000 811 000
totalPayables 703 000 801 000 953 000 1M 806 000
otherPayables 0 0 48 000 64 000 80 000
accruedExpenses 1M 1M 2M 2M 3M
capitalLeaseObligationsCurrent 155 000 852 000 1M 1M 717 000
capitalLeaseObligationsNonCurrent 0 155 000 1M 2M 5M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 285M 285M 279M 258M 239M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-07 2025-08-14 2024-11-12 2024-08-13 2024-05-13 2023-11-09 2023-08-10 2023-05-15 2022-11-10 2022-08-11
acceptedDate 2025-11-07 16:15:06 2025-08-14 17:02:38 2025-04-30 16:08:32 2024-11-12 17:00:09 2024-08-13 17:16:56 2024-05-13 15:31:07 2024-04-29 14:07:07 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18 2022-03-31 17:30:23 2021-03-31 17:00:35
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome 856 000 -4M -4M -2M 1M -2M -14M -3M 818 000 -9M -16M -3M -4M -16M -6M
depreciationAndAmortization 7000 15 000 765 000 -153 000 17 000 228 000 287 000 89 000 67 000 71 000 479 000 90 000 141 000 1M 662 000
deferredIncomeTax 0 0 0 0 0 0 0 -796 000 -10M 0 0 0 0 0 -107 000
stockBasedCompensation 0 86 000 0 155 000 102 000 138 000 717 000 162 000 199 000 212 000 1M 314 000 323 000 2M 2M
changeInWorkingCapital 830 000 -659 000 -1M 736 000 -138 000 -598 000 -3M -381 000 -2M -115 000 1M 1M -2M -3M -11M
accountsReceivables 176 000 -224 000 -762 000 -111 000 -88 000 -246 000 184 000 162 000 7000 80 000 592 000 2M -1M -40 000 -1M
inventory 33 000 -204 000 550 000 -286 000 137 000 303 000 -2M -72 000 -1M -37 000 1M 70 000 332 000 -2M -10M
accountsPayables 458 000 -417 000 -303 000 -107 000 66 000 -678 000 -522 000 -151 000 0 -149 000 -757 000 -643 000 -49 000 -372 000 -580 000
otherWorkingCapital 163 000 186 000 -931 000 1M -253 000 23 000 13 000 -320 000 -532 000 -9000 97 000 -304 000 0 -125 000 -13 000
otherNonCashItems -2M 3M -5M -89 000 -3M 660 000 432 000 608 000 6M 6M -1 000 000 -2M 1M -9M -15M
netCashProvidedByOperatingActivities -257 000 -2M -10M -2M -2M -3M -15M -3M -5M -3M -14M -3M -3M -26M -30M
investmentsInPropertyPlantAndEquipment 0 0 -2M 2M -2M -13 000 -5000 0 -5000 0 -72 000 0 -6000 -1M -2M
acquisitionsNet 0 0 334 000 0 -2M 17 000 569 000 5000 284 000 285 000 569 000 285 000 0 -4M 3M
purchasesOfInvestments 0 0 0 0 0 0 -8M 0 -5M 0 0 0 0 0 -1M
salesMaturitiesOfInvestments 0 0 5M 0 0 0 3M 0 5M 0 0 0 0 22M 18M
otherInvestingActivites 0 250 000 -2M 9M 17 000 5000 -5M 30 000 56 000 54 000
netCashUsedForInvestingActivites 0 250 000 180 000 5M 4000 5000 -5M 315 000 341 000 48 000
debtRepayment 0 0 0 0 0 -382 000 -191 000 0 0 -446 000
commonStockIssued 1000 0 -5000 0 5000 7000 0 6M 5M 0
commonStockRepurchased 0 0 0 0 0 0 0 0 85M 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 4000 0 5000 382 000 191 000 -492 000 -485 000 446 000
netCashUsedProvidedByFinancingActivities 1000 0 4000 0 5000 7000 85M 6M 5M 0
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 -85M 0 0 0 0 2000 0
netChangeInCash -256 000 -2M -2M -2M 2M -3M -14M -3M -10M 2M -8M 1M -3M 13M 8M
cashAtEndOfPeriod 1M 1M 4M 4M 6M 3M 7M 11M 13M 23M 21M 23M 21M 29M 16M
cashAtBeginningOfPeriod 1M 3M 7M 6M 3M 7M 21M 13M 23M 21M 29M 21M 25M 16M 8M
operatingCashFlow -257 000 -2M -10M -2M -2M -3M -15M -3M -5M -3M -14M -3M -3M -26M -30M
capitalExpenditure 0 0 -16 000 2M -3000 -13 000 -5000 0 -5000 0 -72 000 0 -6000 -1M -2M
freeCashFlow -257 000 -2M -10M 248 000 -2M -3M -15M -3M -5M -3M -14M -3M -3M -27M -33M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-04-30 2024-04-29 2023-03-30 2022-03-31 2021-03-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 4M 115 000 920 000 19 000 8000
netCashProvidedByInvestingActivities 7M -4M 1M 17M 17M
netDebtIssuance 0 0 0 -2M 3M
longTermNetDebtIssuance 0 0 0 -2M 3M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 9000 6M 5M 25M 8M
netCommonStockIssuance 9000 6M 5M 25M 8M
commonStockIssuance 9000 6M 5M 25M 8M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 0 -485 000 -481 000 -1M 9M
netCashProvidedByFinancingActivities 9000 6M 5M 22M 21M
incomeTaxesPaid 0 0 0 1000 1000
interestPaid 0 0 1000 25 000 10000

Earning call transcript

2025 q1
2025-05-08 ET (fiscal 2025 q1)
2024 q4
2025-03-20 ET (fiscal 2024 q4)
2024 q3
2024-11-12 ET (fiscal 2024 q3)
2024 q2
2024-08-13 ET (fiscal 2024 q2)
2024 q1
2024-05-09 ET (fiscal 2024 q1)
2023 q4
2024-03-28 ET (fiscal 2023 q4)
2023 q3
2023-11-10 ET (fiscal 2023 q3)
2023 q2
2023-08-10 ET (fiscal 2023 q2)
2023 q1
2023-05-11 ET (fiscal 2023 q1)
2022 q4
2023-03-30 ET (fiscal 2022 q4)
2022 q3
2022-11-10 ET (fiscal 2022 q3)
2022 q2
2022-08-11 ET (fiscal 2022 q2)
2022 q1
2022-05-12 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-07 16:15 ET
Arcadia Biosciences reported for 2025 q3
SEC form 8
2025-11-07 16:12 ET
Arcadia Biosciences published news for 2025 q3
SEC form 8
2025-11-07 16:12 ET
Arcadia Biosciences published news for 2025 q3
SEC form 8
2025-11-07 16:12 ET
Arcadia Biosciences published news for 2025 q3
SEC form 8
2025-10-24 19:13 ET
Arcadia Biosciences published news for 2025 q3
SEC form 10
2025-08-14 21:02 ET
Arcadia Biosciences reported for 2025 q2
SEC form 8
2025-08-14 20:33 ET
Arcadia Biosciences published news for 2025 q2
SEC form 8
2025-08-14 20:33 ET
Arcadia Biosciences published news for 2025 q2
SEC form 8
2025-08-14 20:33 ET
Arcadia Biosciences published news for 2025 q2
SEC form 8
2025-05-16 21:21 ET
Arcadia Biosciences published news for 2025 q1
SEC form 10
2025-05-08 12:07 ET
Arcadia Biosciences published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
Arcadia Biosciences reported for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-08 00:00 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-02 21:01 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-05-02 21:01 ET
Arcadia Biosciences published news for 2025 q1
SEC form 8
2025-04-03 20:15 ET
Arcadia Biosciences published news for 2025 q1
SEC form 10
2025-03-25 20:44 ET
Arcadia Biosciences published news for 2024 q4
SEC form 10
2025-03-25 00:00 ET
Arcadia Biosciences published news for 2024 q4
SEC form 8
2025-03-20 00:00 ET
Arcadia Biosciences published news for 2024 q4
SEC form 8
2025-03-20 00:00 ET
Arcadia Biosciences published news for 2024 q4
SEC form 8
2025-03-20 00:00 ET
Arcadia Biosciences reported for 2024 q4
SEC form 10
2024-11-12 17:00 ET
Arcadia Biosciences reported for 2024 q3
SEC form 8
2024-11-12 16:10 ET
Arcadia Biosciences published news for 2024 q3
SEC form 8
2024-11-12 16:10 ET
Arcadia Biosciences published news for 2024 q3
SEC form 8
2024-11-12 16:10 ET
Arcadia Biosciences published news for 2024 q3
SEC form 10
2024-11-12 00:00 ET
Arcadia Biosciences published news for 2024 q3
SEC form 10
2024-08-13 00:00 ET
Arcadia Biosciences reported for 2024 q2
SEC form 8
2024-08-13 00:00 ET
Arcadia Biosciences published news for 2024 q2
SEC form 8
2024-08-13 00:00 ET
Arcadia Biosciences published news for 2024 q2
SEC form 8
2024-08-13 00:00 ET
Arcadia Biosciences published news for 2024 q2
SEC form 10
2024-05-13 00:00 ET
Arcadia Biosciences published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Arcadia Biosciences published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Arcadia Biosciences published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Arcadia Biosciences reported for 2024 q1
SEC form 10
2024-03-28 17:20 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences reported for 2023 q4
SEC form 10
2024-03-28 00:00 ET
Arcadia Biosciences published news for 2023 q4
SEC form 10
2023-11-09 17:03 ET
Arcadia Biosciences reported for 2023 q3
SEC form 8
2023-11-09 16:10 ET
Arcadia Biosciences published news for 2023 q3
SEC form 10
2023-11-09 00:00 ET
Arcadia Biosciences published news for 2023 q3
SEC form 10
2023-08-10 17:09 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-08-10 16:19 ET
Arcadia Biosciences reported for 2023 q2
SEC form 10
2023-08-10 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 8
2023-08-10 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-07-20 14:55 ET
Arcadia Biosciences published news for 2023 q2
SEC form 8
2023-07-20 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-06-12 16:12 ET
Arcadia Biosciences published news for 2023 q1
SEC form 10
2023-05-15 00:00 ET
Arcadia Biosciences published news for 2023 q1
SEC form 6
2023-05-11 16:26 ET
Arcadia Biosciences published news for 2023 q1
SEC form 8
2023-05-11 00:00 ET
Arcadia Biosciences published news for 2023 q1
SEC form 6
2023-04-13 16:07 ET
Arcadia Biosciences published news for 2023 q1
SEC form 10
2023-03-30 17:09 ET
Arcadia Biosciences reported for 2022 q4
SEC form 6
2023-03-30 16:07 ET
Arcadia Biosciences published news for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Arcadia Biosciences reported for 2022 q4
SEC form 8
2023-03-30 00:00 ET
Arcadia Biosciences reported for 2022 q4
SEC form 6
2023-03-03 16:16 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-02-28 16:12 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-02-22 16:10 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-01-06 16:11 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-01-05 16:14 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2022-12-23 16:12 ET
Arcadia Biosciences published news for 2022 q3
SEC form 6
2022-12-08 16:18 ET
Arcadia Biosciences published news for 2022 q3
SEC form 6
2022-11-30 16:32 ET
Arcadia Biosciences published news for 2022 q3
SEC form 10
2022-11-10 16:53 ET
Arcadia Biosciences reported for 2022 q3
SEC form 6
2022-11-10 16:11 ET
Arcadia Biosciences published news for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Arcadia Biosciences reported for 2022 q3
SEC form 8
2022-11-10 00:00 ET
Arcadia Biosciences reported for 2022 q3
SEC form 6
2022-09-27 16:46 ET
Arcadia Biosciences published news for 2022 q2
SEC form 6
2022-08-16 17:00 ET
Arcadia Biosciences published news for 2022 q2
SEC form 10
2022-08-11 17:09 ET
Arcadia Biosciences reported for 2022 q2
SEC form 6
2022-08-11 16:07 ET
Arcadia Biosciences published news for 2022 q2
SEC form 10
2022-08-11 00:00 ET
Arcadia Biosciences reported for 2022 q2
SEC form 8
2022-08-11 00:00 ET
Arcadia Biosciences reported for 2022 q2
SEC form 6
2022-06-07 16:44 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-05-12 16:59 ET
Arcadia Biosciences reported for 2022 q1
SEC form 6
2022-05-12 16:07 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Arcadia Biosciences reported for 2022 q1
SEC form 8
2022-05-12 00:00 ET
Arcadia Biosciences reported for 2022 q1
SEC form 6
2022-04-19 13:51 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-03-31 17:30 ET
Arcadia Biosciences published news for 2021 q4
SEC form 10
2022-03-31 00:00 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2022-03-30 16:09 ET
Arcadia Biosciences published news for 2021 q4
SEC form 8
2022-03-30 00:00 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2022-02-07 16:26 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2021-12-20 17:03 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-11-19 16:29 ET
Arcadia Biosciences published news for 2021 q3
SEC form 10
2021-11-15 16:53 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-11-15 16:08 ET
Arcadia Biosciences published news for 2021 q3
SEC form 10
2021-11-15 00:00 ET
Arcadia Biosciences published news for 2021 q3
SEC form 8
2021-11-15 00:00 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-10-12 13:44 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-09-07 16:48 ET
Arcadia Biosciences published news for 2021 q2
SEC form 10
2021-08-16 17:06 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-08-16 16:10 ET
Arcadia Biosciences published news for 2021 q2
SEC form 10
2021-08-16 00:00 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-08-02 16:57 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-20 16:00 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-06 16:02 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-02 15:32 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-06-07 17:14 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-05-21 15:59 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-05-17 17:05 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-05-17 16:10 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-05-17 00:00 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-04-20 15:01 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-03-31 17:00 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-03-30 16:51 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-02-24 15:48 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-01-29 11:34 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2020-12-22 12:32 ET
Arcadia Biosciences published news for 2020 q3
SEC form 6
2020-11-18 15:44 ET
Arcadia Biosciences published news for 2020 q3
SEC form 10
2020-11-13 14:47 ET
Arcadia Biosciences published news for 2020 q3
SEC form 6
2020-11-12 08:00 ET
Arcadia Biosciences published news for 2020 q3